Press Releases Nov 30, 2022 Innoviva Announces FDA Acceptance and Priority Review of New Drug Application for Sulbactam-Durlobactam (SUL-DUR) Nov 09, 2022 Innoviva Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress Sep 08, 2022 Innoviva to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference View all press releases Presentations & Events View all presentations & events Form 8937 View Form 8937 - September 30, 2015 View Form 8937
Nov 30, 2022 Innoviva Announces FDA Acceptance and Priority Review of New Drug Application for Sulbactam-Durlobactam (SUL-DUR)
Nov 09, 2022 Innoviva Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress